Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

A pilot study of the duodenal-jejunal bypass liner in low body mass index type 2 diabetes.

Cohen RV, Neto MG, Correa JL, Sakai P, Martins B, Schiavon CA, Petry T, Salles JE, Mamedio C, Sorli C.

J Clin Endocrinol Metab. 2013 Feb;98(2):E279-82. doi: 10.1210/jc.2012-2814. Epub 2013 Jan 21.

PMID:
23337729
2.

Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes.

de Jonge C, Rensen SS, Verdam FJ, Vincent RP, Bloom SR, Buurman WA, le Roux CW, Schaper NC, Bouvy ND, Greve JW.

Obes Surg. 2013 Sep;23(9):1354-60. doi: 10.1007/s11695-013-0921-3.

PMID:
23526068
3.

Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner.

de Moura EG, Martins BC, Lopes GS, Orso IR, de Oliveira SL, Galvão Neto MP, Santo MA, Sakai P, Ramos AC, Garrido Júnior AB, Mancini MC, Halpern A, Cecconello I.

Diabetes Technol Ther. 2012 Feb;14(2):183-9. doi: 10.1089/dia.2011.0152. Epub 2011 Sep 20.

PMID:
21932999
4.

Baseline glycated hemoglobin levels are associated with duodenal-jejunal bypass liner-induced weight loss in obese patients.

Muñoz R, Dominguez A, Muñoz F, Muñoz C, Slako M, Turiel D, Pimentel F, Sharp A, Escalona A.

Surg Endosc. 2014 Apr;28(4):1056-62. doi: 10.1007/s00464-013-3283-y. Epub 2013 Nov 7.

PMID:
24196558
5.

Weight loss and metabolic improvement in morbidly obese subjects implanted for 1 year with an endoscopic duodenal-jejunal bypass liner.

Escalona A, Pimentel F, Sharp A, Becerra P, Slako M, Turiel D, Muñoz R, Bambs C, Guzmán S, Ibáñez L, Gersin K.

Ann Surg. 2012 Jun;255(6):1080-5. doi: 10.1097/SLA.0b013e31825498c4.

PMID:
22534421
6.

Pilot clinical study of an endoscopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes.

Rodriguez L, Reyes E, Fagalde P, Oltra MS, Saba J, Aylwin CG, Prieto C, Ramos A, Galvao M, Gersin KS, Sorli C.

Diabetes Technol Ther. 2009 Nov;11(11):725-32. doi: 10.1089/dia.2009.0063.

PMID:
19905889
7.

The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial.

Koehestanie P, de Jonge C, Berends FJ, Janssen IM, Bouvy ND, Greve JW.

Ann Surg. 2014 Dec;260(6):984-92. doi: 10.1097/SLA.0000000000000794.

PMID:
25072436
8.

Duodenal-jejunal bypass liner to treat type 2 diabetes mellitus in morbidly obese patients.

Muñoz R, Escalona A.

Curr Cardiol Rep. 2014 Mar;16(3):454. doi: 10.1007/s11886-013-0454-3. Review.

PMID:
24570355
9.

Glycemic control after stomach-sparing duodenal-jejunal bypass surgery in diabetic patients with low body mass index.

Cohen R, Caravatto PP, Correa JL, Noujaim P, Petry TZ, Salles JE, Schiavon CA.

Surg Obes Relat Dis. 2012 Jul-Aug;8(4):375-80. doi: 10.1016/j.soard.2012.01.017. Epub 2012 Feb 2.

PMID:
22410638
10.

Role of proximal gut exclusion from food on glucose homeostasis in patients with Type 2 diabetes.

Cohen R, le Roux CW, Papamargaritis D, Salles JE, Petry T, Correa JL, Pournaras DJ, Galvao Neto M, Martins B, Sakai P, Schiavon CA, Sorli C.

Diabet Med. 2013 Dec;30(12):1482-6. doi: 10.1111/dme.12268. Epub 2013 Jul 19.

PMID:
23802863
11.

Clinical improvement after duodenojejunal bypass for nonobese type 2 diabetes despite minimal improvement in glycemic homeostasis.

Ferzli GS, Dominique E, Ciaglia M, Bluth MH, Gonzalez A, Fingerhut A.

World J Surg. 2009 May;33(5):972-9. doi: 10.1007/s00268-009-9968-7.

PMID:
19288284
12.

Diabetes remission and insulin secretion after gastric bypass in patients with body mass index <35 kg/m2.

Lee WJ, Chong K, Chen CY, Chen SC, Lee YC, Ser KH, Chuang LM.

Obes Surg. 2011 Jul;21(7):889-95. doi: 10.1007/s11695-011-0401-6.

PMID:
21499957
13.

Duodenal-jejunal bypass for the treatment of type 2 diabetes in Chinese patients with an average body mass index<24 kg/m2.

Jiang F, Zhu H, Zheng X, Tu J, Zhang W, Xie X.

Surg Obes Relat Dis. 2014 Jul-Aug;10(4):641-6. doi: 10.1016/j.soard.2013.09.001. Epub 2013 Sep 13.

PMID:
24238729
14.

Effects of Duodenal-Jejunal Bypass Liner (EndoBarrier®) on Gastric Emptying in Obese and Type 2 Diabetic Patients.

de Moura EG, Lopes GS, Martins Bda C, Orso IR, Coutinho AM, de Oliveira SL, Sakai P, Galvão-Neto Mdos P, Santo MA, Sapienza MT, Cecconello I, Buchpiguel CA.

Obes Surg. 2015 Sep;25(9):1618-25. doi: 10.1007/s11695-015-1594-x.

PMID:
25691349
15.

Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates.

Gersin KS, Rothstein RI, Rosenthal RJ, Stefanidis D, Deal SE, Kuwada TS, Laycock W, Adrales G, Vassiliou M, Szomstein S, Heller S, Joyce AM, Heiss F, Nepomnayshy D.

Gastrointest Endosc. 2010 May;71(6):976-82. doi: 10.1016/j.gie.2009.11.051. Epub 2010 Mar 20.

PMID:
20304396
16.

Surgery for nonobese type 2 diabetic patients: an interventional study with duodenal-jejunal exclusion.

Geloneze B, Geloneze SR, Fiori C, Stabe C, Tambascia MA, Chaim EA, Astiarraga BD, Pareja JC.

Obes Surg. 2009 Aug;19(8):1077-83. doi: 10.1007/s11695-009-9844-4. Epub 2009 May 12.

PMID:
19475464
17.

Moderate effect of duodenal-jejunal bypass surgery on glucose homeostasis in patients with type 2 diabetes.

Klein S, Fabbrini E, Patterson BW, Polonsky KS, Schiavon CA, Correa JL, Salles JE, Wajchenberg BL, Cohen R.

Obesity (Silver Spring). 2012 Jun;20(6):1266-72. doi: 10.1038/oby.2011.377. Epub 2012 Jan 19.

18.

Duodenal-jejunal bypass improves glucose metabolism and adipokine expression independently of weight loss in a diabetic rat model.

Hu C, Zhang G, Sun D, Han H, Hu S.

Obes Surg. 2013 Sep;23(9):1436-44. doi: 10.1007/s11695-013-0976-1.

PMID:
23636998
20.

[Effect of blood glucose control after small intestine exclusion surgery in Goto-Kakizaki rat with type 2 diabetes mellitus].

Wang Y, Zhang ZZ, Wang L, Deng ZZ, Jiao YB, Zou ZD.

Zhonghua Yi Xue Za Zhi. 2009 Nov 3;89(40):2858-61. Chinese.

PMID:
20137669
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk